Rocket Lab Corp Files 8-K on Equity Sales
Ticker: RKLB · Form: 8-K · Filed: Sep 25, 2025 · CIK: 1819994
| Field | Detail |
|---|---|
| Company | Rocket Lab Corp (RKLB) |
| Form Type | 8-K |
| Filed Date | Sep 25, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $75 m, $75 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, filing-update
Related Tickers: RKLB
TL;DR
Rocket Lab sold unregistered equity, watch for dilution.
AI Summary
On September 25, 2025, Rocket Lab Corporation filed an 8-K report detailing unregistered sales of equity securities and other events. The company, formerly known as Vector Acquisition Corp, is incorporated in Delaware and headquartered in Long Beach, California.
Why It Matters
This filing indicates potential dilution or changes in share structure due to unregistered equity sales, which could impact existing shareholders.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can signal financial needs or dilution, requiring careful monitoring by investors.
Key Players & Entities
- Rocket Lab Corporation (company) — Registrant
- September 25, 2025 (date) — Date of earliest event reported
- Vector Acquisition Corp (company) — Former Name
- Long Beach, California (location) — Principal Executive Offices
FAQ
What type of equity securities were sold unregistered?
The filing does not specify the type of equity securities sold unregistered, only that such sales occurred.
Were these sales part of a private placement or other exemption from registration?
The filing indicates 'Unregistered Sales of Equity Securities' but does not detail the specific exemption claimed.
What is the total value or number of shares involved in these unregistered sales?
The filing does not provide specific dollar amounts or share quantities for the unregistered sales.
When did the name change from Vector Acquisition Corp to Rocket Lab Corporation?
The name change from Vector Acquisition Corp occurred on August 3, 2020.
What is Rocket Lab Corporation's fiscal year end?
Rocket Lab Corporation's fiscal year end is December 31.
Filing Stats: 798 words · 3 min read · ~3 pages · Grade level 15.4 · Accepted 2025-09-25 16:05:29
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share RKLB The Nasdaq Stock Market
- $75 m — exchange for aggregate consideration of $75 million, consisting in cash or shares of
- $75 million — e Purchase Agreement provides for up to $75 million in potential additional post-closing ea
Filing Documents
- rklb-20250925.htm (8-K) — 27KB
- 0001819994-25-000010.txt ( ) — 141KB
- rklb-20250925.xsd (EX-101.SCH) — 2KB
- rklb-20250925_lab.xml (EX-101.LAB) — 21KB
- rklb-20250925_pre.xml (EX-101.PRE) — 12KB
- rklb-20250925_htm.xml (XML) — 3KB
02 Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities. The information set forth in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. The Company Common Stock consideration to be issued, if any, in connection with the Transaction will be issued in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and/or Regulation D thereunder, as a transaction by an issuer not involving a public offering.
01 Other Items
Item 8.01 Other Items. On September 25, 2025, Rocket Lab Corporation, a Delaware corporation (the "Company"), entered into a Stock Purchase Agreement (together with the ancillary documents thereto, the "Purchase Agreement"), by and among the Company, Rocket Lab USA, Inc., a Delaware corporation and wholly-owned subsidiary of the Company ("Buyer"), OC III LVS LIII LP, a Delaware limited partnership ("OC III") and CO Finance II LVS I LLC, a Delaware limited liability company ("COF II" and together with OC III, the "Sellers"), which provides for, among other things, Buyer's purchase and acquisition of all of the issued and outstanding ordinary shares of Mynaric AG, a stock corporation ( Aktiengesellschaft ) incorporated under the laws of the Federal Republic of Germany ("Mynaric"). Pursuant to the terms of the Purchase Agreement, all of the issued and outstanding ordinary shares of Mynaric will be purchased in exchange for aggregate consideration of $75 million, consisting in cash or shares of the Company's common stock, $0.0001 par value ("Company Common Stock"), at the Company's discretion, subject to adjustments at closing (the "Transaction"). Additionally, the Purchase Agreement provides for up to $75 million in potential additional post-closing earnout payments to Sellers in cash or shares of Company Common Stock based on revenue targets of the Mynaric business for 2025, 2026 and 2027. The Company Common Stock issuable as stock consideration in the Transaction will be valued based on the volume weighted average price for the twenty (20) consecutive trading days ending on (and including) the trading day that is immediately preceding the day prior to the Closing Date (as defined in the Purchase Agreement) or the earnout payment date, as applicable. The Purchase Agreement contains representations, warranties, covenants and closing conditions from and for the benefit of each of the Company and Sellers that are customary for transactions of this kind. The Company ha
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROCKET LAB CORPORATION Date: September 25, 2025 By: /s/ Adam Spice Adam Spice Chief Financial Officer